SN
Sweta Nathani
About Sweta Nathani
Data last updated:
Sweta Nathani is a Managing Director at Novocardia Life Science Private Limited (since 2023) and Designated Partner at Nova Grain Llp (since 2026). The companies operate in Pharma. The largest current company by reported revenue is Novocardia Life Science Private Limited at ₹1.45 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novocardia Life Science Private Limited U24110WB2019PTC233252 | Managing Director | 25 Feb 2023 | 2019 | ₹1.45 Cr (FY 2024) | Active |
| Nova Grain Llp ACU-5340 | Designated Partner | 20 Jan 2026 | 2026 | Active |
Board colleagues of Sweta Nathani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aaditya Kumar | 08321180 | Novocardia Life Science Private Limited | Whole-Time Director |
| Anshu Kumar Agrawal | 08527864 | Novocardia Life Science Private Limited | Director |
| Mamta Nathani | 09459339 | Nova Grain Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sweta Nathani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sweta Nathani
Sweta Nathani currently holds 2 directorships: Novocardia Life Science Private Limited (Managing Director, since 25 Feb 2023, revenue ₹1.45 Cr (FY 2024)); Nova Grain Llp (Designated Partner, since 20 Jan 2026).
Sweta Nathani was first appointed on 25 Feb 2023 as Managing Director at Novocardia Life Science Private Limited. The most recent appointment on record is 20 Jan 2026 at Nova Grain Llp.
The current boards of Sweta Nathani's companies include Aaditya Kumar (Novocardia Life Science Private Limited), Anshu Kumar Agrawal (Novocardia Life Science Private Limited), Mamta Nathani (Nova Grain Llp).